World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
66
Citations
15487
World Ranking
2762
National Ranking
1314

James H. Finke publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where James H. Finke sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 258 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

James H. Finke D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where James H. Finke sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 66 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

James H. Finke is affiliated with the Cleveland Clinic Lerner College of Medicine in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with specific focus on subfields such as Immunology, Oncology, Surgery, Pulmonary and Respiratory Medicine, and Molecular Biology.

The scientist's research centers on topics including immune cells in cancer, renal cell carcinoma treatment, inflammatory biomarkers in disease prognosis, bladder and urothelial cancer treatments, cancer immunotherapy and biomarkers, CAR-T cell therapy research, and inflammation biomarkers and pathways.

Finke has published articles in several recognized venues. These include Frontiers in Oncology, Nature Reviews Nephrology, Targeted Oncology, Molecular Immunology, and Clinical Genitourinary Cancer. Among their frequent co-authors are Brian I. Rini, C. Marcela Díaz-Montero, Pat Rayman, Patricia Rayman, and Jin S. Kim.

Some of their recent notable papers are:

  • The immunology of renal cell carcinoma, 2020, Nature Reviews Nephrology
  • Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell Carcinoma, 2022, Frontiers in Oncology
  • Blood Myeloid-Derived Suppressor Cells Correlate with Neutrophil-to-Lymphocyte Ratio and Overall Survival in Metastatic Urothelial Carcinoma, 2020, Targeted Oncology
  • Healthy myeloid-derived suppressor cells express the surface ectoenzyme Vanin-2 (VNN2), 2021, Molecular Immunology
  • Myeloid-Derived Suppressor Cells in Nonmetastatic Urothelial Carcinoma of Bladder Is Associated With Pathologic Complete Response and Overall Survival, 2020, Clinical Genitourinary Cancer

Best Publications

  • Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients

    Jennifer S. Ko;Arnold H. Zea;Brian I. Rini;Joanna L. Ireland

  • Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients

    James H. Finke;Brian I Rini;Joanna Ireland;Patricia Rayman

  • Loss of T-Cell Receptor ζ Chain and p56lck in T-Cells Infiltrating Human Renal Cell Carcinoma

    James H. Finke;Arnold H. Zea;Jill Stanley;Dan L. Longo

  • The immunology of renal cell carcinoma

    C. Marcela Díaz-Montero;Brian I. Rini;James H. Finke

  • Direct and Differential Suppression of Myeloid-Derived Suppressor Cell Subsets by Sunitinib Is Compartmentally Constrained

    Jennifer S. Ko;Patricia Rayman;Joanna Ireland;Shadi Swaidani

  • Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma

    Baisakhi Raychaudhuri;Patricia Rayman;Joanna Ireland;Jennifer Ko

  • MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.

    James Finke;Jennifer Ko;Brian Rini;Pat Rayman

  • Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.

    Ulrich Keilholz;Jeffrey Weber;James H. Finke;Dmitry I. Gabrilovich

  • The CXC Chemokines IP-10 and Mig Are Necessary for IL-12-Mediated Regression of the Mouse RENCA Tumor

    Charles S. Tannenbaum;Raymond Tubbs;David Armstrong;James H. Finke

  • Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4+ T Cell Responses Against MAGE-6 in HLA-DRB10401+ Patients With Renal Cell Carcinoma or Melanoma

    Tomohide Tatsumi;Lisa S. Kierstead;Elena Ranieri;Elena Ranieri;Loreto Gesualdo

  • The Cardioprotective Protein Apolipoprotein A1 Promotes Potent Anti-tumorigenic Effects

    Maryam Zamanian-Daryoush;Daniel J Lindner;Thomas C. Tallant;Zeneng Wang

  • Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial

    Brian I Rini;Tanya B. Dorff;Paul Elson;Cristina Suarez Rodriguez

  • Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion

    Balint Otvos;Daniel J Silver;Erin E Mulkearns-Hubert;Alvaro G Alvarado

  • Where have all the T cells gone? Mechanisms of immune evasion by tumors

    James Finke;Soldano Ferrone;Alan Frey;Allan Mufson

  • T-Cells Infiltrating Renal Cell Carcinoma Display a Poor Proliferative Response Even Though They Can Produce Interleukin 2 and Express Interleukin 2 Receptors

    Jeannine P. Alexander;Seiji Kudoh;Kathryn A. Melsop;Thomas A. Hamilton

  • Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α.

    Yana G. Najjar;Patricia Rayman;Xuefei Jia;Paul G. Pavicic

  • Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12.

    Charles S. Tannenbaum;Nancy Wicker;David Armstrong;Raymond Tubbs

  • Mechanisms of apoptosis in T cells from patients with renal cell carcinoma.

    Robert G. Uzzo;Patricia Rayman;Vladimir Kolenko;Peter E. Clark

  • Clinical Perspectives on Targeting of Myeloid Derived Suppressor Cells in the Treatment of Cancer

    Yana George Najjar;James Harold Finke

  • Defining the critical hurdles in cancer immunotherapy

    Bernard A. Fox;Bernard A. Fox;Dolores J. Schendel;Lisa H. Butterfield;Steinar Aamdal

Frequent Co-Authors

Ronald M. Bukowski
Ronald M. Bukowski Cleveland Clinic
Brian I. Rini
Brian I. Rini Vanderbilt University Medical Center
Raymond R. Tubbs
Raymond R. Tubbs Cleveland Clinic
Andrew C. Novick
Andrew C. Novick Cleveland Clinic
Walter J. Storkus
Walter J. Storkus University of Pittsburgh
Eric A. Klein
Eric A. Klein Cleveland Clinic
Marc S. Ernstoff
Marc S. Ernstoff Roswell Park Cancer Institute
Michael A. Vogelbaum
Michael A. Vogelbaum Cleveland Clinic
Peter A. Cohen
Peter A. Cohen Mayo Clinic
Steven C. Campbell
Steven C. Campbell Cleveland Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, branching into nursing can open diverse and rewarding career paths. Many students explore options like the accelerated FNP programs, which quickly prepare registered nurses to become family nurse practitioners with advanced clinical skills.

If you're coming from a non-nursing background, some of the best online BSN programs for non nurses offer flexible pathways to enter the nursing profession, complementing your immunology knowledge with essential practical experience.

For those seeking faster entry points, accelerated nursing programs provide a streamlined approach to earning a Bachelor of Science in Nursing, ideal for advancing your healthcare career without prolonged study periods.

Alternatively, the fastest and easiest LPN programs can be a practical choice to start working in clinical settings quickly while gaining foundational skills that complement immunology expertise.

Best Scientists Citing James H. Finke

Trending Scientists